Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy

NCT01675882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Peanut Allergy

Interventions

BIOLOGICAL: Viaskin Peanut 50 mcg
BIOLOGICAL: Viaskin Peanut 100 mcg
BIOLOGICAL: Viaskin Peanut 250 mcg
BIOLOGICAL: Viaskin Placebo

Sponsor

DBV Technologies